Press Releases
Jun
19
2019
Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders
May
28
2019
May
20
2019
May
16
2019
May
07
2019
May
02
2019
Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders
Apr
30
2019
Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Apr
01
2019
Mar
13
2019
Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference
Feb
28
2019
Displaying 31 - 40 of 119